About Bangqi Bio
Bangqi Bio is a Healthcare company based in Suzhou (China) founded in 2020. It operates as an instruments and reagents for immune disorder diagnosis are developed. Its focus areas include Life Sciences, Immunology, In Vitro Diagnostic Tests and Allergies.
Company details
Founded in 2020 in Suzhou, China, instruments and reagents for the diagnosis of immune disorders are developed by Bangqi Bio. A dual-array, high-throughput diagnostic system is provided, focusing on autoimmune conditions and allergies within the biotechnology sector. Operations center on creating tools for clinical diagnostics, supporting healthcare applications in immunology.
- Headquarters Suzhou, China
- SectorsHealthcare
- InvestorsShanghai Dunhong Asset Management
& 1 more
Funding Insights of Bangqi Bio
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Bangqi Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | – | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Bangqi Bio
Bangqi Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Shanghai Dunhong Asset Management and The Relay Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | dh-capital.cn | - | |
- | – | stepfund.cn | - |
Investor details for Bangqi Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bangqi Bio
2 dated milestones of Bangqi Bio across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Bangqi Bio is founded.
- Funding First funding round.
Top companies in Infectious Diseases
10 companies that operate in the same segment as Bangqi Bio (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | 172 | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | 329 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bangqi Bio
Bangqi Bio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Bangqi Bio is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Founded in 2020 in Suzhou, China, instruments and reagents for the diagnosis of immune disorders are developed by Bangqi Bio. A dual-array, high-throughput diagnostic system is provided, focusing on autoimmune conditions and allergies within the biotechnology sector. Operations center on creating tools for clinical diagnostics, supporting healthcare applications in immunology.
Bangqi Bio has 2 investors. Key investors include Shanghai Dunhong Asset Management, and The Relay Fund.